ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation

Becher LRE., et al.
December 2020
Authors and Affiliates
Laura R E Becher 1,2, Wendy K Nevala 2, Shari Lee Sutor 2, Megan Abergel 3,4,5, Michele M Hoffmann 1, Christopher A Parks 1, Larry R Pease 1, Adam G Schrum 3,4,5, Svetomir N Markovic 2, Diana Gil 3,4,5; 1Department of Immunology, Mayo Clinic Graduate School of Biomedical Sciences, and. 2Department of Oncology, Mayo Clinic, Rochester, MN; and. 3Department of Surgery, School of Medicine. 4Department of Molecular Microbiology & Immunology, School of Medicine, and. 5Department of Bioengineering, College of Engineering, University of Missouri, Columbia, MO.